These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9846897)

  • 1. Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung.
    Fehrenbach H; Kasper M; Tschernig T; Shearman MS; Schuh D; Müller M
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1147-57. PubMed ID: 9846897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
    Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
    Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene.
    Katsuoka F; Kawakami Y; Arai T; Imuta H; Fujiwara M; Kanma H; Yamashita K
    Biochem Biophys Res Commun; 1997 Sep; 238(2):512-6. PubMed ID: 9299542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human and rat recombinant receptors for advanced glycation end products have a high degree of homology but different pharmacokinetic properties in rats.
    Renard C; Chappey O; Wautier MP; Nagashima M; Morser J; Scherrmann JM; Wautier JL
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1458-66. PubMed ID: 10454525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
    Yonekura H; Yamamoto Y; Sakurai S; Petrova RG; Abedin MJ; Li H; Yasui K; Takeuchi M; Makita Z; Takasawa S; Okamoto H; Watanabe T; Yamamoto H
    Biochem J; 2003 Mar; 370(Pt 3):1097-109. PubMed ID: 12495433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.
    Harashima A; Yamamoto Y; Cheng C; Tsuneyama K; Myint KM; Takeuchi A; Yoshimura K; Li H; Watanabe T; Takasawa S; Okamoto H; Yonekura H; Yamamoto H
    Biochem J; 2006 May; 396(1):109-15. PubMed ID: 16503878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR.
    Katz J; Bhattacharyya I; Farkhondeh-Kish F; Perez FM; Caudle RM; Heft MW
    J Clin Periodontol; 2005 Jan; 32(1):40-4. PubMed ID: 15642057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of advanced glycation end products with A549 cells, a human pulmonary epithelial cell line, is mediated by a receptor distinct from the scavenger receptor family and RAGE.
    Nakano N; Fukuhara-Takaki K; Jono T; Nakajou K; Eto N; Horiuchi S; Takeya M; Nagai R
    J Biochem; 2006 May; 139(5):821-9. PubMed ID: 16751589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products: sparking the development of diabetic vascular injury.
    Goldin A; Beckman JA; Schmidt AM; Creager MA
    Circulation; 2006 Aug; 114(6):597-605. PubMed ID: 16894049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia.
    De Vriese AS; Tilton RG; Mortier S; Lameire NH
    Nephrol Dial Transplant; 2006 Sep; 21(9):2549-55. PubMed ID: 16757496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responses.
    Sevillano N; Girón MD; Salido M; Vargas AM; Vilches J; Salto R
    J Biochem; 2009 Jan; 145(1):21-30. PubMed ID: 18849572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RAGE axis in early diabetic retinopathy.
    Barile GR; Pachydaki SI; Tari SR; Lee SE; Donmoyer CM; Ma W; Rong LL; Buciarelli LG; Wendt T; Hörig H; Hudson BI; Qu W; Weinberg AD; Yan SF; Schmidt AM
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2916-24. PubMed ID: 16043866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs).
    Collison KS; Parhar RS; Saleh SS; Meyer BF; Kwaasi AA; Hammami MM; Schmidt AM; Stern DM; Al-Mohanna FA
    J Leukoc Biol; 2002 Mar; 71(3):433-44. PubMed ID: 11867681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
    Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Fukami K; Okuda S; Imaizumi T
    Microvasc Res; 2008 Jan; 75(1):130-4. PubMed ID: 17560613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of the receptor for glycation endproducts (RAGE) in oral squamous cell carcinomas.
    Landesberg R; Woo V; Huang L; Cozin M; Lu Y; Bailey C; Qu W; Pulse C; Schmidt AM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):617-24. PubMed ID: 18206396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging.
    Yan SF; D'Agati V; Schmidt AM; Ramasamy R
    Curr Mol Med; 2007 Dec; 7(8):699-710. PubMed ID: 18331228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation in receptor for advanced glycation end-products in inflammatory circumstances in bovine coccygeal intervertebral disc specimens in vitro.
    Yoshida T; Park JS; Yokosuka K; Jimbo K; Yamada K; Sato K; Takeuchi M; Yamagishi S; Nagata K
    Spine (Phila Pa 1976); 2009 Jul; 34(15):1544-8. PubMed ID: 19564763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AGE/RAGE axis in diabetes-accelerated atherosclerosis.
    Jandeleit-Dahm K; Watson A; Soro-Paavonen A
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):329-34. PubMed ID: 18290873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-kappaB activation.
    Matsunaga N; Anan I; Forsgren S; Nagai R; Rosenberg P; Horiuchi S; Ando Y; Suhr OB
    Acta Neuropathol; 2002 Nov; 104(5):441-7. PubMed ID: 12410391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes.
    Cuccurullo C; Iezzi A; Fazia ML; De Cesare D; Di Francesco A; Muraro R; Bei R; Ucchino S; Spigonardo F; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A; Cipollone F
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2716-23. PubMed ID: 17038636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.